These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24187842)

  • 1. [Preparation of valsartan nanosuspensions and its in vitro dissolution].
    Li F; Song SS; Liu Y; Guo YX; Pan WS; Yang XG
    Yao Xue Xue Bao; 2013 Aug; 48(8):1312-8. PubMed ID: 24187842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.
    Liu D; Xu H; Tian B; Yuan K; Pan H; Ma S; Yang X; Pan W
    AAPS PharmSciTech; 2012 Mar; 13(1):295-304. PubMed ID: 22246736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of self-nanoemulsifying drug delivery system for oral bioavailability enhancement of valsartan in beagle dogs.
    Li Z; Zhang W; Gao Y; Xiang R; Liu Y; Hu M; Zhou M; Liu X; Wang Y; He Z; Sun Y; Sun J
    Drug Deliv Transl Res; 2017 Feb; 7(1):100-110. PubMed ID: 27812915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.
    Xu Y; Liu X; Lian R; Zheng S; Yin Z; Lu Y; Wu W
    Int J Pharm; 2012 Nov; 438(1-2):287-95. PubMed ID: 22989976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of azithromycin nanosuspensions by reactive precipitation method.
    Hou CD; Wang JX; Le Y; Zou HK; Zhao H
    Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Central Composite Design in Optimization of Valsartan Nanosuspension to Enhance its Solubility and Stability.
    Vuppalapati L; Cherukuri S; Neeli V; Yeragamreddy PR; Kesavan BR
    Curr Drug Deliv; 2016; 13(1):143-57. PubMed ID: 26205900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
    Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM
    Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nano-suspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.
    Xie Y; Chen Z; Su R; Li Y; Qi J; Wu W; Lu Y
    Curr Drug Deliv; 2017; 14(4):483-491. PubMed ID: 27593183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline state.
    Ma Q; Sun H; Che E; Zheng X; Jiang T; Sun C; Wang S
    Int J Pharm; 2013 Jan; 441(1-2):75-81. PubMed ID: 23266761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
    Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of press coated tablets of release engineered valsartan for pulsatile delivery.
    Shah S; Patel R; Soniwala M; Chavda J
    Drug Dev Ind Pharm; 2015; 41(11):1835-46. PubMed ID: 25721985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro-in vivo characterization of trans-resveratrol nanosuspensions.
    Dong Q; Yuan HL; Qian JJ; Zhang CY; Chen WD
    Biomed Mater Eng; 2018; 29(3):333-345. PubMed ID: 29578462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of effect of variables on particle size of telmisartan nanosuspensions using box-Behnken design.
    Rao MR; Bajaj A
    Drug Res (Stuttg); 2014 Dec; 64(12):663-7. PubMed ID: 24549965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
    Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
    Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.
    Alshweiat A; Katona G; Csóka I; Ambrus R
    Eur J Pharm Sci; 2018 Sep; 122():94-104. PubMed ID: 29908301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
    Wang Y; Han X; Wang J; Wang Y
    Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and stability evaluation of extemporaneous oral suspension of valsartan using commercially available tablets.
    Zaid AN; Assali M; Qaddomi A; Ghanem M; Zaaror YA
    Int J Pharm Compd; 2014; 18(2):169-74. PubMed ID: 24881122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.